Conference Call with Manorama Industries Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Food & Beverages company Manorama Industries announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: The company reported revenue of Rs 39,134.09 lakh for Q4FY26, representing a growth of 7.94% QoQ from Rs 36,253.79 lakh in Q3FY26 and a significant increase of 68.10% YoY from Rs 23,280.58 lakh in Q4FY25. For FY26, revenue stood at Rs 1,36,673.89 lakh, up 77.30% YoY from Rs 77,084.19 lakh in FY25. Total Income: Total income for Q4FY26 was Rs 38,425.45 lakh, an increase of 2.70% QoQ compared to Rs 37,413.53 lakh and up 58.57% YoY from Rs 24,232.69 lakh. For FY26, total income reached Rs 1,37,709.20 lakh, growing by 73.91% YoY from Rs 79,184.62 lakh. Net Profit: The company earned a net profit of Rs 4,248.13 lakh in Q4FY26, a decline of 41.22% QoQ from Rs 7,227.15 lakh, but an increase of 6.09% YoY from Rs 4,004.14 lakh. For FY26, net profit was Rs 21,494.04 lakh, reflecting a robust growth of 95.78% YoY from Rs 10,978.95 lakh in FY25. Total Comprehensive Income: For Q4FY26, total comprehensive income stood at Rs 4,077.96 lakh, while For FY26, it reached Rs 21,316.47 lakh, up 94.35% YoY from Rs 10,967.99 lakh. Earnings Per Share (EPS): The basic and diluted EPS for FY26 stood at Rs 36.00 and Rs 35.99 respectively, compared to Rs 18.42 and Rs 18.35 in FY25. Standalone Financial Highlights: Revenue from Operations: Standalone revenue for Q4FY26 was Rs 38,229.93 lakh, up 5.45% QoQ from Rs 36,253.79 lakh and up 64.21% YoY from Rs 23,280.58 lakh. For FY26, it stood at Rs 1,35,769.73 lakh, a growth of 76.13% YoY. Total Income: Standalone total income for Q4FY26 reached Rs 37,696.81 lakh, while the annual total income for FY26 was Rs 1,36,905.25 lakh, compared to Rs 78,940.53 lakh in FY25. Net Profit: Standalone net profit for Q4FY26 was Rs 5,951.68 lakh, a decrease of 12.79% QoQ from Rs 6,824.45 lakh but an increase of 40.81% YoY from Rs 4,226.67 lakh. For FY26, net profit was Rs 23,321.97 lakh, up 108.14% YoY from Rs 11,205.01 lakh in FY25. Business Highlights: Segment-wise Performance: The company operates in a single identifiable reportable business segment, which is the "Manufacturing of Exotic Seed based Fats and Butters including Cocoa Butter Equivalent (CBE)". Dividend Recommendation: The Board of Directors recommended a final dividend of Rs 0.80 per equity share (40% of the face value of Rs 2/- each) for the financial year 2025-26. Capex and Global Expansion: The Board approved a proposal to support the establishment of a processing factory in Burkina Faso through its subsidiary, Taang Kaam Industries SA. The financial assistance includes an equity investment of up to Rs 150 crore and unsecured loans or corporate guarantees up to Rs 100 crore each. Strategic Acquisition: The company acquired WOKADINE, marking its entry into the Rs 648 crore Povidone Iodine market, funded through internal accruals. Market Relaunch: Relaunched key brands Fostine R and Menodac under Women’s Health Therapeutics, and Noklot in the Cardiovascular segment. Market Positioning: The company improved its industry ranking to 27th rank in India, moving up 5 spots in the last three years. Certifications: Obtained EAEU-GMP certification, enabling entry into markets including Russia, Belarus, Kazakhstan, Armenia, and Kyrgyzstan. Result PDF